To assess the feasibility of a PCSK9-based heart attack vaccine, Zhang et al. create a PCSK9 mimic and demonstrate in mice and NHPs its ability to significantly reduce cholesterol. This evidence concerns the gene PCSK9 and myocardial infarction.